Ignite Creation Date:
2024-05-06 @ 3:15 PM
Last Modification Date:
2025-12-16 @ 11:45 PM
Study NCT ID:
NCT04576117
Status:
None
Last Update Posted:
2025-11-19 00:00:00
First Post:
2020-10-03 00:00:00
Brief Title:
A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute (NCI)
Organization Data
Organization:
National Cancer Institute (NCI)
Class:
NIH
Study ID:
NCI-2020-07549
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Cancer Institute NCI
Lead Sponsor Class:
NIH
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None